Ghp Investment Advisors, Inc. Amgen Inc Transaction History

Ghp Investment Advisors, Inc.

  • $2.15 Billion
  • Q3 2024

A detailed history of Ghp Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 24,914 shares of AMGN stock, worth $6.98 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
24,914
Previous 23,909 4.2%
Holding current value
$6.98 Million
Previous $7.47 Million 7.46%
% of portfolio
0.37%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$309.38 - $337.38 $310,926 - $339,066
1,005 Added 4.2%
24,914 $8.03 Million
Q2 2024

Aug 08, 2024
BUY
$262.75 - $319.31 $454,557 - $552,406
1,730 Added 7.8%
23,909 $7.47 Million
Q1 2024

Apr 25, 2024
BUY
$268.87 - $324.56 $220,473 - $266,139
820 Added 3.84%
22,179 $6.31 Million
Q4 2023

Jan 26, 2024
BUY
$255.7 - $288.46 $181,802 - $205,095
711 Added 3.44%
21,359 $6.15 Million
Q3 2023

Oct 17, 2023
BUY
$218.65 - $271.46 $114,572 - $142,245
524 Added 2.6%
20,648 $5.55 Million
Q2 2023

Aug 14, 2023
BUY
$214.27 - $253.37 $370,258 - $437,823
1,728 Added 9.39%
20,124 $4.47 Million
Q1 2023

Apr 21, 2023
BUY
$225.79 - $275.2 $214,500 - $261,440
950 Added 5.45%
18,396 $4.45 Million
Q4 2022

Feb 16, 2023
BUY
$229.03 - $291.01 $223,991 - $284,607
978 Added 5.94%
17,446 $4.58 Million
Q3 2022

Oct 28, 2022
BUY
$224.46 - $253.15 $173,507 - $195,684
773 Added 4.93%
16,468 $3.71 Million
Q2 2022

Aug 11, 2022
BUY
$230.71 - $256.74 $287,003 - $319,384
1,244 Added 8.61%
15,695 $3.82 Million
Q1 2022

Apr 28, 2022
BUY
$219.27 - $242.57 $780,162 - $863,064
3,558 Added 32.66%
14,451 $3.49 Million
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $209,022 - $239,207
-1,051 Reduced 8.8%
10,893 $2.45 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $175,971 - $206,172
829 Added 7.46%
11,944 $2.54 Million
Q2 2021

Aug 13, 2021
SELL
$233.58 - $259.14 $437,028 - $484,850
-1,871 Reduced 14.41%
11,115 $2.71 Million
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $260,300 - $303,337
1,173 Added 9.93%
12,986 $3.23 Million
Q4 2020

Feb 12, 2021
BUY
$216.38 - $257.67 $360,921 - $429,793
1,668 Added 16.44%
11,813 $2.72 Million
Q3 2020

Nov 16, 2020
BUY
$234.65 - $260.95 $464,137 - $516,159
1,978 Added 24.22%
10,145 $2.58 Million
Q2 2020

Aug 06, 2020
SELL
$197.81 - $242.74 $100,091 - $122,826
-506 Reduced 5.83%
8,167 $1.93 Million
Q1 2020

May 13, 2020
SELL
$182.24 - $241.7 $75,629 - $100,305
-415 Reduced 4.57%
8,673 $1.76 Million
Q4 2019

Feb 14, 2020
BUY
$189.21 - $243.2 $6,433 - $8,268
34 Added 0.38%
9,088 $2.19 Million
Q3 2019

Nov 07, 2019
SELL
$174.11 - $208.62 $253,330 - $303,542
-1,455 Reduced 13.85%
9,054 $1.75 Million
Q2 2019

Aug 02, 2019
BUY
$166.7 - $195.41 $64,179 - $75,232
385 Added 3.8%
10,509 $1.94 Million
Q1 2019

May 10, 2019
BUY
$180.87 - $203.88 $11,756 - $13,252
65 Added 0.65%
10,124 $1.92 Million
Q4 2018

Feb 13, 2019
BUY
$178.4 - $208.25 $193,742 - $226,159
1,086 Added 12.1%
10,059 $1.96 Million
Q3 2018

Oct 17, 2018
BUY
$185.29 - $208.89 $5,188 - $5,848
28 Added 0.31%
8,973 $1.86 Million
Q2 2018

Aug 17, 2018
SELL
$166.05 - $186.51 $31,383 - $35,250
-189 Reduced 2.07%
8,945 $1.65 Million
Q1 2018

Apr 25, 2018
BUY
$169.43 - $198.0 $21,856 - $25,542
129 Added 1.43%
9,134 $1.56 Million
Q4 2017

Feb 14, 2018
BUY
$168.79 - $188.59 $64,477 - $72,041
382 Added 4.43%
9,005 $1.57 Million
Q3 2017

Nov 03, 2017
BUY
$167.29 - $191.0 $1.44 Million - $1.65 Million
8,623
8,623 $1.61 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ghp Investment Advisors, Inc. Portfolio

Follow Ghp Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email